6-Fluoro-N-(4-fluorobenzyl)quinazolin-4-amine

Catalog No. :
ACVIYT154
CAS No. :
1262888-28-7
Molecular Formula :
C15H11F2N3
Molecular Weight :
271.27

IUPAC Name:6-fluoro-N-(4-fluorobenzyl)quinazolin-4-amine

6-Fluoro-N-(4-fluorobenzyl)quinazolin-4-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg98%$71.00Login to see priceIn stockInquiry
50mg98%$100.00Login to see priceIn stockInquiry
100mg98%$131.00Login to see priceIn stockIn stock
250mg98%$223.00Login to see priceIn stockIn stock
1g98%$599.00Login to see priceIn stockInquiry
5g98%$2168.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Fluoro-N-(4-fluorobenzyl)quinazolin-4-amine
IUPAC Name6-fluoro-N-(4-fluorobenzyl)quinazolin-4-amine
MDL No.MFCD16962292
Molecular FormulaC15H11F2N3
Molecular Weight271.27
SMILESFC1=CC=C(C=C1)CNC2=C3C=C(F)C=CC3=NC=N2
InChI KeyAWIVHRPYFSSVOG-UHFFFAOYSA-N
SynonymCS-4616 | A889470 | CS1815 | MBCQ derivative C43 | NCGC00263555-05 | deoxy-ATP, 2'-deoxyadenosine triphosphate, Deoxyadenosine 5'-triphosphate | EN300-93027 | P2613 | Spautin-1 | CCG-267171 | 6-Fluoro-N-(4-fluorobenzyl)quinazolin-4-amine | HMS3871D13 | EN
CAS No.1262888-28-7
PubChem CID51037431

Synthetic Route by SureRoute

1. ACVIYT154 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHQGZ976 route compound structure diagram
    ACHQGZ976659-41-6 In Stock
  4. Then
  5. ACVIYT154 route product structure diagram
    ACVIYT1541262888-28-7 In Stock
Inquiry

2. ACVIYT154 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVIYT154 route product structure diagram
    ACVIYT1541262888-28-7 In Stock
Inquiry

Comments (0)